CASI Pharmaceuticals Inc
(NASDAQ:CASI)
$5.60
0.40[7.69%]
Last update: 6:37PM (Delayed 15-Minutes)
Get Real Time Here
$5.60
0[0.00%]
Open-Close-
Vol / Avg.0 / 31.484KMkt Cap74.600M
Day Range- - -52 Wk Range1.450 - 5.940

CASI Pharmaceuticals Stock (NASDAQ:CASI), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$12.00

Lowest Price Target1

$3.80

Consensus Price Target1

$9.45

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
40000

Analyst Firms Making Recommendations1

  • HC Wainwright & Co.
  • BTIG
  • Mizuho

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for CASI Pharmaceuticals

All Ratings (11)

Upgrades (0)

Downgrades (0)

Initiations (2)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/15/2023CASIBuy Now
CASI Pharmaceuticals
$5.60114.29%HC Wainwright & Co.
Sean Lee
$10 → $12MaintainsBuyGet Alert
08/14/2023CASIBuy Now
CASI Pharmaceuticals
$5.6078.57%HC Wainwright & Co.
Sean Lee
→ $10ReiteratesBuy → BuyGet Alert
05/22/2023CASIBuy Now
CASI Pharmaceuticals
$5.6078.57%HC Wainwright & Co.
Sean Lee
→ $10ReiteratesBuy → BuyGet Alert
11/16/2022CASIBuy Now
CASI Pharmaceuticals
$5.6078.57%BTIG
Justin Zelin
$21 → $10MaintainsBuyGet Alert
11/15/2022CASIBuy Now
CASI Pharmaceuticals
$5.6078.57%HC Wainwright & Co.
Sean Lee
$12 → $10MaintainsBuyGet Alert
08/15/2022CASIBuy Now
CASI Pharmaceuticals
$5.60114.29%HC Wainwright & Co.
Swayampakula Ramakanth
$3 → $12MaintainsBuyGet Alert
06/03/2022CASIBuy Now
CASI Pharmaceuticals
$5.60275%BTIG
Justin Zelin
$4 → $21MaintainsBuyGet Alert
05/16/2022CASIBuy Now
CASI Pharmaceuticals
$5.60-46.43%HC Wainwright & Co.
Sean Lee
$40 → $30MaintainsBuyGet Alert
05/18/2021CASIBuy Now
CASI Pharmaceuticals
$5.60-28.57%BTIG
Justin Zelin
Initiates → BuyGet Alert
05/14/2021CASIBuy Now
CASI Pharmaceuticals
$5.60-28.57%HC Wainwright & Co.
Sean Lee
MaintainsBuyGet Alert
04/26/2021CASIBuy Now
CASI Pharmaceuticals
$5.60-32.14%Mizuho
Difei Yang
Initiates → BuyGet Alert
Q

What is the target price for CASI Pharmaceuticals (CASI)?

A

The latest price target for CASI Pharmaceuticals (NASDAQ: CASI) was reported by HC Wainwright & Co. on November 15, 2023. The analyst firm set a price target for $12.00 expecting CASI to rise to within 12 months (a possible 114.29% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for CASI Pharmaceuticals (CASI)?

A

The latest analyst rating for CASI Pharmaceuticals (NASDAQ: CASI) was provided by HC Wainwright & Co., and CASI Pharmaceuticals maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for CASI Pharmaceuticals (CASI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CASI Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CASI Pharmaceuticals was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.

Q

Is the Analyst Rating CASI Pharmaceuticals (CASI) correct?

A

While ratings are subjective and will change, the latest CASI Pharmaceuticals (CASI) rating was a maintained with a price target of $10.00 to $12.00. The current price CASI Pharmaceuticals (CASI) is trading at is $5.60, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.